Total number of females studied* | Number of DNA variants* | Location | Nucleotide change | Aminoacid change | Domain | Effect | Reference** |
---|---|---|---|---|---|---|---|
60 p | 1 p | Exon 8 | c.509_510insGT | p.Glu170GlyfsX36 | Catalytic | Pathogenic | NEW, this study |
60 p | 1 p | Exon 10 | c.745-?_825 + ?del | ---------- | Catalytic | Pathogenic | NEW, this study |
160 (60p + 100c) | 1 p | Exon 12 | c.1455_1460delGGCCAA | p.Ala486_Lys487del | C-Ter | Unknown Variation | NEW, this study |
160 (60p + 100c) | 7 (1p + 6 c) | Exon 17 | c.2389 G > A | p.Asp797Asn | C-Ter | Polymorphism | NEW, this study |
160 (60p + 100c) | 6 (1p + 5 c) | Before exon 1 | c.-426 C > G | ---------- | ------ | Polymorphism | NEW, this study |
60 p | 1 p | Intron 6 | c.403 + 27A > G | ---------- | ------ | Without pathogenic effect | NEW, this study |
160 (60p + 100c) | 2 (1p + 1c) | Exon 21 | c.2995 G > A | p.Val999Met | C-Ter | Polymorphism (SNP: rs35693326) | |
160 (60p + 100c) | 6 (2p + 4c) | Before exon 1 | c.-391 G > T | ---------- | ------ | Polymorphism | Evans et al. [12] |
60 p | 2 p | Exon 4, 21 | c.145 + 17A > G; c. 3003 C > G; c. 3084 G > A | p.His1001His; p.Thr1028Thr | Catalytic, C-Ter | Polymorphism | Tao et al. [28] |